Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration - ScienceDirect
The Future of Rare Disease Research: Ethics, Treatments, and Access - Penn Medicine
UPENN Biomedical Graduate Studies | James M. Wilson
2020 Update on Gene Therapy for CNS Diseases Dr Jim Wilson 2020 FAST Science Summit - YouTube
Penn Medicine Study: Attacking a Rare Disease at its Source With Gene Therapy | Penn Today
Newly Approved Spinal Muscle Atrophy Treatment Zolgensma is Based on Delivery System Discovered by Penn Gene Therapy Pioneer - Penn Medicine
Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors: Molecular Therapy - Methods & Clinical Development
Gene therapy pioneer devises new tactic to curb side effects of treatment
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
Gene Therapy Pioneer James Wilson Joins RSRT Consortium; Resigns from Advisory Role at IPO-Bound Solid Biosciences
Penn Medicine at the ASGCT Annual Meeting
COVID-19 Vaccine, AAVCOVID | Mass. Eye and Ear
UPenn Gene Therapy Program Joining Discovery Labs Ecosystem | BioBuzz
Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia: Molecular Therapy - Methods & Clinical Development
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters | Gene Therapy
Jim Wilson launches liver disease gene-editing company iECURE with $50 million
Repurposing a proven gene therapy approach to treat, prevent COVID-19 | Penn Today
Penn Medicine News on X: "Dr. James Wilson's deal with @amicusrx1 is named Deal of the Year. It formed a collaboration between Amicus and @PennMedicine's gene therapy program #PennInnovators2018 https://t.co/TBmlTXZV1N" / X
Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates: Molecular Therapy - Methods & Clinical Development
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals | The Scientist Magazine®
Gene Therapy Pioneer, Regeneron Partner on Nasal Spray vs. COVID-19: Penn's James M. Wilson, MD, PhD, brings his program's AAV expertise to collaboration with the developer of the antibody 'cocktail' taken by
The doctor responsible for gene therapy's greatest setback is sounding a new alarm | MIT Technology Review
James Wilson, M.D., Ph.D. receives Pioneer Aw | EurekAlert!
Biologic Therapeutics Center - Washington University School of Medicine
Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project - Penn Medicine
The Death of Jesse Gelsinger, 20 Years Later | Science History Institute
Home | Gene Therapy Program | Perelman School of Medicine at the University of Pennsylvania
